r google-plus facebook twitter linkedin2 nujij M Monitor Nieuwsbrief pdclogo man met tas twitter boek

13th Pharmacovigilance Conference, Amsterdam

datum 29 januari 2020
plaats Amsterdam
locatie HILTON HOTEL, Amsterdam Toon locatie
organisatie Medicines for Europe

2020 PROGRAMME

REGISTER NOW

HOTEL ACCOMMODATION

Please book your accommodation by phoning +31-(0) 20-7106014 or sending an email to carlijn.swagemakers@hilton.com

ADVERTISING, EXHIBITION & SPONSORSHIP OPPORTUNITIES

Medicines for Europe Pharmacovigilance Conference

The Medicines for Europe annual Pharmacovigilance Conference is more than a traditional conference. It is a unique opportunity to learn about the latest trends, to engage with renowned experts, and to personally develop as a healthcare professional.

The 13th Pharmacovigilance Conference will take place for the very first time in Amsterdam at the Hilton Hotel on 29th January 2020.

Take the opportunity to learn from regulators and leading experts and discover what the challenges and opportunities will be in the field of Pharmacovigilance in 2020.

What can you expect from the Conference programme in 2020?

Our sessions will allow conference attendees to catch up on all recent activities and to prepare themselves for upcoming challenges and milestones such as:

  • How globalisation is impacting pharmacovigilance
  • The end of the signal detection pilot: what does the future hold for Marketing Authorisation Holders?
  • Finding out about the lifecycle approach in pharmacovigilance and how it can leverage risk minimisation
  • Measuring the impact of pharmacovigilance activities
  • Discovering the latest trends in compliance and inspections
  • How we can simplify and reduce burden in the pharmacovigilance system
  • How to maximise work sharing and improve system efficiency for industry and regulators

Do not miss out on these exciting discussions. Join us to discover and learn from the experts who will be joining us in Amsterdam in 2020.

We look forward to seeing you there!

Inhoud

jQuery(document).ready(function($){ $("#team-8569 .team-items").owlCarousel({ items : 5, //10 items above 1000px browser width autoHeight:true, responsiveClass:true, responsive:{ 0:{ items:1, nav:true }, 600:{ items:2, nav:true }, 900:{ items:2, nav:true }, 1000:{ items:5, nav:true, } }, navText : ["",""], nav: true, }); });

Adrian van den Hoven

Director General, Medicines for Europe

Adrian van den HovenDirector General, Medicines for Europe

Sabine Straus

Dutch Representative of the PRAC, Chair, Medicines Evaluation Board

Sabine StrausDutch Representative of the PRAC, Chair, Medicines Evaluation Board

Dr. med. Sebastian Horn

Head Patient Safety, Sandoz International and Chair PV Working Group, Medicines for Europe

Dr. med. Sebastian HornHead Patient Safety, Sandoz International and Chair PV Working Group, Medicines for Europe

Kaisa Immonen

Director of Policy, European Patients' Forum (EPF)

Kaisa ImmonenDirector of Policy, European Patients' Forum (EPF)

Shanti Pal

Group Lead, Medicines Safety, WHO

Shanti PalGroup Lead, Medicines Safety, WHO

Martin Huber

PRAC Vice Chair, BfArM

Martin HuberPRAC Vice Chair, BfArM

Uwe Gudat

Head of Clinical Safety & Pharmacovigilance Biosimilars, Fresenius Kabi SwissBioSim GmbH

Uwe GudatHead of Clinical Safety & Pharmacovigilance Biosimilars, Fresenius Kabi SwissBioSim GmbH

Peter Arlett

Head of Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)

Peter ArlettHead of Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)

Sophie Radicke

GPvP Inspector, MRHA

Sophie RadickeGPvP Inspector, MRHA

Fakhredin Sayed Tabatabaei, MD, PhD

Project Manager ePI (electronic Product Information), MEB

Fakhredin Sayed Tabatabaei, MD, PhDProject Manager ePI (electronic Product Information), MEB

Andrew Donaldson

European Head of PV Technology Services, IQVIA

Andrew DonaldsonEuropean Head of PV Technology Services, IQVIA

Andreas Iwanowitsch

Head Global Pharmacovigilance Unit, STADA Arzneimittel AG

Andreas IwanowitschHead Global Pharmacovigilance Unit, STADA Arzneimittel AG

Georgy Genov

Head of Signal and Incident Management, Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)

Georgy GenovHead of Signal and Incident Management, Pharmacovigilance and Epidemiology Department, European Medicines Agency (EMA)

Kora Doorduyn-van der Stoep

Vice-Chairperson CMDh (NL) and CMDh Member/Senior Policy Adviser, Medicines Evaluation Board (NL)

Kora Doorduyn-van der StoepVice-Chairperson CMDh (NL) and CMDh Member/Senior Policy Adviser, Medicines Evaluation Board (NL)

Klaudija Marijanović Barać

Head Global PSUR & RMP Unit, Teva

Klaudija Marijanović BaraćHead Global PSUR & RMP Unit, Teva

Benedicte Lunddahl

Head of Pharmacovigilance Section, Danish Medicines Agency (DK)

Benedicte LunddahlHead of Pharmacovigilance Section, Danish Medicines Agency (DK)

Paul Fleming

Technical Director, British Generic Manufacturers Association

Paul FlemingTechnical Director, British Generic Manufacturers Association

Susana Almeida, PhD

Clinical Development and Safety Director, Medicines for Europe

Susana Almeida, PhDClinical Development and Safety Director, Medicines for Europe

TBN

TBN

See highlights from our 2019 event

Video

Photo Gallery

Press Release

To secure your place at this ‘must attend’ platform, please register now and you too can share information with leading experts and network with your peers.

Follow the event on Twitter: #PHV20

Medicines for Europe is honored to be collaborating with the following partners to make this year’s conference

2.

CONTACT

Lucia Romagnoli

M: +44 (0) 7 562 87 68 73

For more information on advertising, exhibition and sponsorship packages:

Trudy Beks

M: +31 6 4119 0824

Media Requirements and Press Policy

For any other media enquiries:

Kate O’Regan

P: +32 (0)2 239 2019


3.

Meer over...

Terug naar boven